Quantitative trait locus mapping of genes that control body length and plasma insulin-like growth factor 1 level in mice

BMC Research Notes

Jun-ichi Suto¹ 

[1] Agrogenomics Research Center, National Institute of Agrobiological Sciences, Tsukuba, Ibaraki, 305-8634, Japan

关键词: Quantitative trait locus (QTL);    Plasma IGF1 levels;    Body length;    A^y allele;   

Others  :  1165532
DOI  :  10.1186/1756-0500-5-547

 received in 2012-06-18, accepted in 2012-09-20,  发布年份 2012

【 摘 要 】

Background

The A^y allele at the agouti locus causes obesity and promotes linear growth in mice. The effect of the A^y allele on obesity has been extensively investigated, whereas its effect on body length is only poorly analyzed. To gain insight into the genetic control of body length, quantitative trait locus (QTL) analysis was performed in F₂ female mice produced by crossing C57BL/6 J females and DDD.Cg-A^y males. A congenic DDD.Cg-A^y strain was established by introgressing the A^y allele from the B6.Cg-A^y strain by backcrossing for 12 generations. DDD.Cg-A^y females were longer than B6.Cg-A^y females; therefore, QTLs that interact with the A^y allele may be identified for body length. In addition, QTL analysis was also performed for plasma insulin-like growth factor 1 (IGF1) levels because IGF1 is known to play essential roles in growth and development. If QTLs for IGF1 levels coincide with those for body length, we can gain endocrinological insight into the QTLs for body length.

Results

Correlations between body length and IGF1 levels were statistically significant in F₂ populations. For body length, two significant QTLs were identified on chromosomes 15 and 17. For IGF1 levels, three significant QTLs were identified on chromosomes 10, 12, and 19. QTLs on chromosomes 12 and 19 appeared to be novel, and the latter interacted with the A^y allele.

Conclusion

QTLs for body length and IGF1 levels contained candidate genes that were components of the growth hormone/insulin-like growth factor axis. However, there was no overlap between QTLs for these two traits. Contrary to our expectations, QTLs that interacted with the A^y allele were identified not for body length but for IGF1 levels. Body length and IGF1 levels were, thus, controlled by different sets of genes.

【 授权许可】

   
2012 Suto; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Leibel RL, Chung WK, Chua SC Jr: The molecular genetics of rodent single gene obesities. J Biol Chem 1997, 272:31937-31940.
• [2]Heston WE, Vlahakis G: Influence of the Ay gene on mammary-gland tumors, hepatomas, and normal growth in mice. J Natl Cancer Inst 1961, 26:969-983.
• [3]Bultman SJ, Michaud EJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell 1992, 71:1195-1204.
• [4]Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS: Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 1993, 7:454-467.
• [5]Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Rosell-Rehfuss L, Baack E, Mountjoy KG, Cone RD: Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993, 26:827-834.
• [6]Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinson WO, Cone RD: Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371:799-802.
• [7]Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS: Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994, 8:59-65.
• [8]Michaud EJ, Bultman SJ, Stubbs LJ, Woychik RP: The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein. Genes Dev 1993, 7:1203-1213.
• [9]Michaud EJ, Bultman SJ, Klebig ML, van Vugt MJ, Stubbs LJ, Russell LB, Woychik RP: A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc Natl Acad Sci USA 1994, 91:2562-2566.
• [10]Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, Maclntyre DE, Chen HY, Van der Ploeg LH: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000, 26:97-102.
• [11]Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
• [12]Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-138.
• [13]Suto J: The Ay allele at the agouti locus reduces the size and alters the shape of the mandible in mice. Proc Jpn Acad Ser B 2009, 85:248-257.
• [14]Suto J: Quantitative trait loci that control body weight and obesity in an F2 intercross between C57BL/6J and DDD.Cg-Ay mice. J Vet Med Sci 2011, 73:907-915.
• [15]Martin NM, Houston PA, Patterson M, Sajedi A, Carmignac DF, Ghatei MA, Bloom SR, Small CJ: Abnormalities of the somatotrophic axis in the obese agouti mouse. Int J Obes 2006, 30:430-438.
• [16]Martinelli CE, Keogh JM, Greenfield JR, Henning E, van der Klaauw AA, Blackwood A, O’Rahilly S, Roelfsema F, Camacho-Hübner C, Pijl H, Farooqi IS: Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final weight, fasting hyperglycemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab 2011, 96:E181-E188.
• [17]Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73-82.
• [18]Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
• [19]Masinde GL, Li X, Gu W, Davidson H, Hamilton-Ulland M, Wergedal J, Mohan S, Baylink DJ: Quantitative trait loci (QTL) for lean body mass and body length in MRL/MPJ and SJL/J F2 mice. Funct Integr Genomics 2002, 2:98-104.
• [20]Masinde GL, Li X, Gu W, Hamilton-Ulland M, Mohan S, Baylink DJ: Quantitative trait loci that harbor genes regulating muscle size in (MRL/MPJ × SJL/J) F2 mice. Funct Integr Genomics 2002, 2:120-125.
• [21]Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA: IGF-1 is required for normal embryonic growth in mice. Genes Dev 1993, 7:2609-2617.
• [22]Suto J: Identification of multiple quantitative trait loci affecting the size and shape of the mandible in mice. Mamm Genome 2009, 20:1-13.
• [23]Reed DR, Li X, McDaniel AH, Lu K, Li S, Tordoff MG, Price RA, Bachmanov AA: Loci on chromosomes 2, 4, 9, and 16 for body weight, body length, and adiposity identified in a genome scan of an F2 intercross between the 129P3/J and C57BL/6ByJ mouse strains. Mamm Genome 2003, 14:302-313.
• [24]Farber CR, Medrano JF: Fine mapping reveals sex bias in quantitative trait loci affecting growth, skeletal size and obesity-related traits on mouse chromosomes 2 and 11. Genetics 2007, 175:349-360.
• [25]Chiu S, Kim K, Haus KA, Espinal GM, Millon LV, Warden CH: Identification of positional candidate genes for body weight and adiposity in subcongenic mice. Physiol Genomics 2007, 31:75-85.
• [26]Shibata Y, Tsukazaki T, Hirata K, Xin C, Yamaguchi A: Role of a new member of IGFBP superfamily, IGFBP-rP10, in proliferation and differentiation of osteoblastic cells. Biochem Biophys Res Commun 2004, 325:1194-1200.
• [27]Brockmann GA, Kratzsch J, Haley CS, Renne U, Schwerin M, Karle S: Single QTL effects, epistasis, and pleiotropy account for two-thirds of the phenotypic F2 variance of growth and obesity in Du6i × DBA/2 mice. Genome Res 2000, 10:1941-1957.
• [28]Rosen CJ, Churchill GA, Donahue LR, Shultz KL, Burgess JK, Powell DR, Beamer WG: Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice. Bone 2000, 27:521-528.
• [29]Harper JM, Galecki AT, Burke DT, Pinkosky SL, Miller RA: Quantitative trait loci for insulin-like growth factor 1, leptin, throxine, and corticosterone in genetically heterogeneous mice. Physiol Genomics 2003, 15:44-51.
• [30]Leduc MS, Hageman RS, Meng Q, Verdugo RA, Tsaih S-W, Churchill GA, Paigen B, Yuan R: Identification of genetic determinants of IGF-1 levels and longevity among mouse inbred strains. Aging Cell 2010, 9:823-836.
• [31]Adamo ML, Ma X, Ackert-Bicknell CL, Donahue LR, Beamer WG, Rosen CJ: Genetic increase in serum insulin-like growth factor-1 (IGF-1) in C3H/HeJ compared with C57BL/6 J mice is associated with increased transcription from the IGF-1 exon 2 promoter. Endocrinology 2006, 147:2944-2955.
• [32]Suto J, Matsuura S, Yamanaka H, Sekikawa K: Quantitative trait loci that regulate plasma lipid concentration in hereditary obese KK and KK-Ay mice. Biochim Biophys Acta 1999, 1453:385-395.
• [33]Broman KW, Sen Ś: A guide to QTL mapping with R/qtl. New York: Springer; 2009.
• [34]Broman KW, Wu H, Sen Ś, Churchill GA: R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003, 19:889-890.
• [35]Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241-247.